Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 182

1.

Gene Expression Assay in the Management of Early Breast Cancer.

Caputo R, Cianniello D, Giordano A, Piezzo M, Riemma M, Trovo M, Berretta M, De-Laurentiis M.

Curr Med Chem. 2019 Dec 5. doi: 10.2174/0929867326666191205163329. [Epub ahead of print]

PMID:
31804159
2.

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results.

Facchini G, Rossetti S, Berretta M, Cavaliere C, Scagliarini S, Vitale MG, Ciccarese C, Di Lorenzo G, Palesandro E, Conteduca V, Basso U, Naglieri E, Farnesi A, Aieta M, Borsellino N, La Torre L, Iovane G, Bonomi L, Gasparro D, Ricevuto E, De Tursi M, De Vivo R, Lo Re G, Grillone F, Marchetti P, De Vita F, Scavelli C, Sini C, Pisconti S, Crispo A, Gebbia V, Maestri A, Galli L, De Giorgi U, Iacovelli R, Buonerba C, Cartenì G, D'Aniello C.

J Transl Med. 2019 Aug 29;17(1):296. doi: 10.1186/s12967-019-2047-4.

3.

Incidence and risk factors of early HCC occurrence in HCV patients treated with direct acting antivirals: a prospective multicentre study.

Rinaldi L, Perrella A, Guarino M, De Luca M, Piai G, Coppola N, Pafundi PC, Ciardiello F, Fasano M, Martinelli E, Valente G, Nevola R, Monari C, Miglioresi L, Guerrera B, Berretta M, Sasso FC, Morisco F, Izzi A, Adinolfi LE.

J Transl Med. 2019 Aug 28;17(1):292. doi: 10.1186/s12967-019-2033-x.

4.

Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology.

Crisci S, Amitrano F, Saggese M, Muto T, Sarno S, Mele S, Vitale P, Ronga G, Berretta M, Di Francia R.

Medicina (Kaunas). 2019 Jul 28;55(8). pii: E414. doi: 10.3390/medicina55080414. Review.

5.

Metastatic Colorectal Cancer: Prognostic And Predictive Factors.

Nappi A, Nasti G, Romano C, Berretta M, Ottaiano A.

Curr Med Chem. 2019 Jun 20. doi: 10.2174/0929867326666190620110732. [Epub ahead of print]

PMID:
31218949
6.

Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas.

Crisci S, Di Francia R, Mele S, Vitale P, Ronga G, De Filippi R, Berretta M, Rossi P, Pinto A.

Front Oncol. 2019 Jun 4;9:443. doi: 10.3389/fonc.2019.00443. eCollection 2019. Review.

7.

Pharmacogenetic-Based Interactions between Nutraceuticals and Angiogenesis Inhibitors.

Di Francia R, Berretta M, Benincasa G, D'Avino A, Facchini S, Costagliola D, Rossi P.

Cells. 2019 May 30;8(6). pii: E522. doi: 10.3390/cells8060522. Review.

8.

Ten daily fractions for partial breast irradiation. Long-term results of a prospective phase II trial.

Vinante L, Avanzo M, Furlan C, Fiorica F, Perin T, Militello L, Spazzapan S, Berretta M, Jena R, Stancanello J, Piccoli E, Mileto M, Micheli E, Roncadin M, Massarut S, Trovò M.

Breast J. 2019 Mar;25(2):243-249. doi: 10.1111/tbj.13195. Epub 2019 Feb 3.

PMID:
30714257
9.

Correction: Sonoporation by microbubbles as gene therapy approach against liver cancer.

Rinaldi L, Folliero V, Palomba L, Zannella C, Isticato R, Di Francia R, Berretta M, de Sio I, Adinolfi LE, Morelli G, Lastoria S, Altucci L, Pedone C, Galdiero M, Franci G.

Oncotarget. 2018 Oct 30;9(85):35600. doi: 10.18632/oncotarget.26305. eCollection 2018 Oct 30.

10.

Integration of stereotactic radiotherapy in the treatment of metastatic colorectal cancer patients: a real practice study with long-term outcome and prognostic factors.

Ottaiano A, Scotti V, De Divitiis C, Capozzi M, Romano C, Cassata A, Casaretti R, Silvestro L, Nappi A, Vicario V, De Stefano A, Tafuto S, Berretta M, Nasti G, Avallone A.

Oncotarget. 2018 Oct 16;9(81):35251-35265. doi: 10.18632/oncotarget.25834. eCollection 2018 Oct 16.

11.

The Genotype for DPYD Risk Variants in Patients With Colorectal Cancer and the Related Toxicity Management Costs in Clinical Practice.

Toffoli G, Innocenti F, Polesel J, De Mattia E, Sartor F, Dalle Fratte C, Ecca F, Dreussi E, Palazzari E, Guardascione M, Buonadonna A, Foltran L, Garziera M, Bignucolo A, Nobili S, Mini E, Favaretto A, Berretta M, D'Andrea M, De Paoli A, Roncato R, Cecchin E.

Clin Pharmacol Ther. 2019 Apr;105(4):994-1002. doi: 10.1002/cpt.1257. Epub 2018 Nov 22.

PMID:
30339275
12.

Sonoporation by microbubbles as gene therapy approach against liver cancer.

Rinaldi L, Folliero V, Palomba L, Zannella C, Isticato R, Di Francia R, Berretta M, de Sio I, Adinolfi LE, Morelli G, Lastoria S, Altucci L, Pedone C, Galdiero M, Franci G.

Oncotarget. 2018 Aug 14;9(63):32182-32190. doi: 10.18632/oncotarget.25875. eCollection 2018 Aug 14. Erratum in: Oncotarget. 2018 Oct 30;9(85):35600.

13.

Editorial: The Real Impact of Target Therapy in Cancer Patients: Between Hope and Reality.

Berretta M, Di Francia R.

Curr Cancer Drug Targets. 2018;18(5):402-404. doi: 10.2174/156800961805180522072538. No abstract available.

PMID:
29956604
14.

B-glucans from Grifola frondosa and Ganoderma lucidum in breast cancer: an example of complementary and integrative medicine.

Rossi P, Difrancia R, Quagliariello V, Savino E, Tralongo P, Randazzo CL, Berretta M.

Oncotarget. 2018 May 15;9(37):24837-24856. doi: 10.18632/oncotarget.24984. eCollection 2018 May 15. Review.

15.

First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis.

Ottaiano A, De Stefano A, Capozzi M, Nappi A, De Divitiis C, Romano C, Silvestro L, Cassata A, Casaretti R, Tafuto S, Caraglia M, Berretta M, Nasti G, Avallone A.

Front Pharmacol. 2018 May 3;9:441. doi: 10.3389/fphar.2018.00441. eCollection 2018. Review.

16.

Coffee consumption is not associated with ovarian cancer risk: a dose-response meta-analysis of prospective cohort studies.

Berretta M, Micek A, Lafranconi A, Rossetti S, Di Francia R, De Paoli P, Rossi P, Facchini G.

Oncotarget. 2018 Apr 17;9(29):20807-20815. doi: 10.18632/oncotarget.24829. eCollection 2018 Apr 17.

17.

Microbiota effects on cancer: from risks to therapies.

Rea D, Coppola G, Palma G, Barbieri A, Luciano A, Del Prete P, Rossetti S, Berretta M, Facchini G, Perdonà S, Turco MC, Arra C.

Oncotarget. 2018 Apr 3;9(25):17915-17927. doi: 10.18632/oncotarget.24681. eCollection 2018 Apr 3. Review.

18.

Can the addition of radiotherapy postoperatively increase clinical outcome of patients with gastric cancer? A systematic review of the literature and meta-analysis.

Fiorica F, Trovò M, Ottaiano A, Nasti G, Carandina I, Marzola M, De Paoli P, Berretta M.

Oncotarget. 2017 Dec 28;9(12):10734-10744. doi: 10.18632/oncotarget.23754. eCollection 2018 Feb 13.

19.

Increased risk of testis failure in testicular germ cell tumor survivors undergoing radiotherapy.

Ghezzi M, De Toni L, Palego P, Menegazzo M, Faggian E, Berretta M, Fiorica F, De Rocco Ponce M, Foresta C, Garolla A.

Oncotarget. 2017 Dec 7;9(3):3060-3068. doi: 10.18632/oncotarget.23081. eCollection 2018 Jan 9.

20.

Exploring the molecular aspects associated with testicular germ cell tumors: a review.

Facchini G, Rossetti S, Cavaliere C, D'Aniello C, Di Franco R, Iovane G, Grimaldi G, Piscitelli R, Muto P, Botti G, Perdonà S, Veneziani BM, Berretta M, Montanari M.

Oncotarget. 2017 Nov 3;9(1):1365-1379. doi: 10.18632/oncotarget.22373. eCollection 2018 Jan 2. Review.

Supplemental Content

Loading ...
Support Center